--- title: "KHPG: Pirfenidone tablets approved for listing" type: "News" locale: "en" url: "https://longbridge.com/en/news/287213596.md" description: "KHPG recently announced that it has obtained the \"Drug Registration Certificate\" for Pirfenidone Tablets issued by the National Medical Products Administration, approving its registration. Pirfenidone Tablets are classified as a Class II psychotropic drug, primarily used for the treatment of neurological disorders associated with neuronal hyperexcitability" datetime: "2026-05-21T11:47:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287213596.md) - [en](https://longbridge.com/en/news/287213596.md) - [zh-HK](https://longbridge.com/zh-HK/news/287213596.md) --- # KHPG: Pirfenidone tablets approved for listing According to the Zhitong Finance APP, KHPG (002773.SZ) announced that it recently received the "Drug Registration Certificate" (Certificate No.: 2026S01622, 2026S01623) for Pirfenidone Tablets issued by the National Medical Products Administration, approving its registration. The active ingredient of Pirfenidone Tablets is Pirfenidone, which is classified as a Class II psychotropic drug according to the national "Regulations on the Administration of Narcotic Drugs and Psychotropic Substances." Pirfenidone is a non-competitive antagonist of the ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor on postsynaptic neurons. Glutamate is the main excitatory neurotransmitter in the central nervous system and is involved in various neurological diseases caused by neuronal hyperexcitability ### Related Stocks - [002773.CN](https://longbridge.com/en/quote/002773.CN.md) ## Related News & Research - [Hayden Panettiere's childhood home relists for $3.7M, echoing memoir's 'brutal' past](https://longbridge.com/en/news/290938974.md) - [Forget Amazon Prime Days: Here's the real reason to buy the stock](https://longbridge.com/en/news/290914469.md) - [$30 billion in stocks are about to hit the market in 2 days, and one strategist says: Buy it](https://longbridge.com/en/news/290991405.md) - [Forget chips. Citrini Research sees hot trades in planes, Baby Boomers, and sold-out stadiums](https://longbridge.com/en/news/290725215.md) - [REG - NWF Group PLC - Holding(s) in Company](https://longbridge.com/en/news/290990897.md)